Filing Flows › BioAge Labs (BIOA) › Q1 2025
BioAge Labs (BIOA) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 6, 2025
BioAge Labs (BIOA) reported revenue of $1.5M for the first quarter 2025 (Q1 2025).
BioAge Labs, Q1 2025: revenue $1.5M, net loss $12.9M, operating cash flow −$17.4M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.5M | — | — |
| Operating profit | −$16.4M | — | — |
| Net earnings | −$12.9M | — | — |
| Operating cash flow | −$17.4M | — | — |
What changed
Revenue was $1.5M in Q1 2025.
Operating costs exceeded revenue by $16.4M, an operating margin of -1133.4%. The quarter ended with a net loss of $12.9M. Non-operating items added $3.5M, -27% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$17.4M. Non-cash charges added back $2.9M of share-based compensation. Working capital and other items used $7.4M. Capital expenditures of $426K exceeded it, leaving free cash flow of −$17.8M.
Questions
What was BioAge Labs' revenue in the first quarter 2025?
BioAge Labs (BIOA) reported revenue of $1.5M for the first quarter 2025 (Q1 2025).
Source: BioAge Labs 10-Q on SEC EDGAR.